为期三天的第二十三届Bio-Europe 于11月6日在德国柏林如期召开。作为欧洲最大的新药会，Bio-Europe不管从参会人员还是项目的数量和质量上，都是其他任何展会所无法比拟的。
INITIATE NEW PARTNERSHIPS THROUGH LIFE SCIENCE PARTNERING AT BIO-EUROPE 2017 IN BERLIN!
This "must-attend" event is Europe's largest life science partnering conference.
BIO-Europe's world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business.
本次会议可谓是座无虚席，吸引了来自2177家公司的多达4056位参会人员，一共有5145个项目转让机会，让人应接不暇。
This Autumn 2177 companies with 4056 delegates are gathered in Berlin, bringing over 5000 licensing opportunities.
灵麦医药作为EvaluatePharma 和Biotechgate两大权威数据库的独家代理也参加了本次盛会。作为中欧医药器械合作的桥梁，灵麦医药致力于支持中国医药行业寻找到合适的项目。
Lingmed, the exclusive sales and client service partner of EvaluatePharma and Biotechgate, also attend this conference, to bridge European and Chinese pharmaceuticals with biotech companies.
作为每年必去的秋季新药盛会，毫无疑问吸引了众多来自中国的行业专家们，大家相聚柏林，共同探讨新的商业机会。
项目推荐：今天灵麦医药将给各位推荐9个正在积极寻求中国市场伙伴的优秀项目
对仿制药感兴趣的客官，不要错过，灵麦医药精选了9个正在寻求中国合作伙伴的仿制药项目，这些项目已经过灵麦分析团队的初步分析，如对项目感兴趣，请联系我们。（本服务仅针对灵麦博谷数据库客户或灵佰服务客户）
公司简介：
LMC5000477是一家总部位于欧洲的知名制药公司。该公司现已在欧洲8 个国家地区设立了生产基地。所有的生产设施都是按照最严格的国际要求进行设计的，符合FDA标准。
现该公司将带着他们 9 大仿药项目来到中国。想要合作么？欢迎联系我们: info@lingmed.net.
If you are interested in Generic products, then don't miss the today's recommendation. Lingmed recommends 9 global generic assets, which are looking for partners in China. All of these assets have analyzed by lingmed team. This partnering service is exclusive for Lingmed database subscriber.
Company introduction:
LMC5000477 is a well Known Company in the APIs production arena using either synthetic or biological processes for Generic market as well as in contract manufacturing (CDMO). LMC5000477 has 8 manufacturing facilities, of which 7 are located in Northern Italy and 1 in Spain. All manufacturing facilities have been designed in compliance with the strictest international requirements and are regularly inspected by the most important national and international Authorities and are also audited by our partners and customers. All are FDA-inspected and self-identified under GDUFA.
Now LMC5000469 bring 9 Generic assets to China looking for partners. Do you want to collaborate with them? Feel free to email us: info@lingmed.net.
Generic asset recommendation
仿药项目推荐
项目分析：
1．阿维A仿药
根据 EvaluatePharma 预估医药数据库，阿维A各品牌中，销量第一的是葛兰素史克的Soriatane，其2016年的销售额为1.35亿美元，根据世界顶级投行的综合预测，到 2022 年稳中有升，将会达到 1.64亿美金的销售额.
根据 Source China 博源数据库，目前中国市场上仅有2 家公司获批生产成剂型次（图 1）。
图 1：阿维A中国注册情况
Asset initial analysis：
1. Acitretin
According to the EvaluatePharma database, the Best sell product in Acitretin is Soriatane from GlaxoSmithKline, with the sales up to 135 million dollars in 2016. By the year of 2022, the sales will reach 164 million dollars.
According to the Source China database, there is only two company has been approved by CFDA to produce formulated Acitretin products.
Figure1：Chinese registration summary for Acitretin
2．阿比特龙仿药
根据 EvaluatePharma 预估医药数据库，阿比特龙各品牌中，销量第一的是强生的Zytiga，其2016年的销售额为22.6亿美元，但由于其专利17年即将到期，根据世界顶级投行的综合预测，到 2022销售额将为7.59亿美金.
根据 Source China 博源数据库，目前中国市场上仅有1家公司获批生产成剂型次（图 2）。
图 2：阿比特龙中国注册情况
2. Abiraterone
According to the EvaluatePharma database, the Best sell product in Abiraterone is Zytiga from Johnson & Johnson, with the sales up to 2260 million dollars in 2016. However, as its patent expires in 2017, by the year of 2022, the sales drop to 759 million dollars.
According to the Source China database, there is only one company has been approved by CFDA to produce Abiraterone.
Figure1：Chinese registration summary for Abiraterone
灵麦公司是行业知名的数据库Biotechgate在中国的独家代理，负责中国市场的产品推广和售后服务。
博谷（Biotechgate）- by Venture Valuation （灵麦是博谷在中国的独家代理）
博谷（Biotechgate）是全球知名的收购，产品引进的平台。由瑞士Venture Valuation公司开发，是全球EBD会议主办方的合作伙伴，目前被全球BD和投资专业人士广泛使用。
Lingmed is the China exclusive sales and client service partner of the renowned database - Biotechgate.
Biotechgate - global innovative assets intelligence database
The database covers over 45,000 Biotech/device companies, over 63,000 innovative products(over 21,000 device products) of various therapeutic areas and all stages
The database contains over 19,000 licensing opportunities (over 5,000 actively seeking partners) with detailed product information and key business contact information
Over 2000 deals with detailed payments to benchmark your own similar deal
The database is very strong for capturing global private biotech companies’ innovative assets active for out-licensing to other markets.
欢迎大家来Biotechgate展台享用瑞士特饮 - SCHÜMLI PFLÜMLI
Welcome to the booth of Biotechgate to enjoy a Swiss drink - SCHÜMLI PFLÜMLI
在欧洲峰会上灵麦和 Xplico 公司达成德克中文版上线的共识。
德克估价助手是对新产品销量预测及交易评估的工具。德克估价助手由丹麦Xplico公司建立，在2006年上市。这个Excel上的附加工具已被众多欧洲中小型的医药和生物科技公司所广泛使用 。灵麦医药将于2018年首次在中国推出德克中文版，灵麦是其在中国的独家代理合作公司
Lingmed met with Xplico at Bio Europe and agreed on launching the Chinese version of Xplico Evaluator.
Xplico Evaluator - Business forecast tool on sales forecast and deal valuation. Xplico evaluator was developed by Danish company Xplico and launched in 2006, this excel add-on tool has been widely used by small and midsize pharmaand biotech companies. Lingmed started to introduce Xplico into China market as its exclusive partner and will launch the Chinese version of valuation tool in 2018!
灵麦医药现还推出灵佰服务，向中国医药市场引进创新药品技术，提高中国患者的生活质量，拯救患者的生命。
Linkedbio灵佰是灵麦医药新推出的项目对接服务,灵麦团队在全球范围内精选优质新药和器械项目,帮助国内医药和器械企业与国外创新研发公司建立商业联系。
Linkedbio 项目引进
为客户提供目标治疗领域的项目初步市场分析,与项目研发公司安排对接会议,线上翻译,提供项目非保密资料,并提供首次洽谈会议后的项目跟进等,帮助国内公司引进创新产品
Linkedbio 市场分析
灵麦分析团队通过对文献搜索分析（包括公司年报和其他新闻评论等）及一线访谈帮助我们的客户完成市场项目分析工作，包括产品在中国的市场销量预估，交易的估值和竞争情报分析报告等
Lingmed provides services to help EU/US biotech companies to enter China market by the right strategy and with the right partner.
Linkedbio Partnering
Lingmed analyst team evaluates the innovative biotech products, technologies and medical devices to estimate the market size, risk & opportunities, to identify the right partner for the asset. Lingmed team will arrange partnering meetings to facilitate the direct dialogues, suggest deal structure to support deal closing
Linkedbio Analysis
Lingmed analyst team conducts desk researches and interviews to get insights on China market, we provide tailored product China market sizing analysis, deal valuation and competitive landscape reports to our clients
灵麦医药是以下两家情报数据库在中国的独家合作伙伴：
Biotechgate/博谷 - 全球创新药和器械产品收购和引进数据库
EvaluatePharma/预估医药 - 全球医药研发、销售、市场预估等竞争情报数据库
想要获取更多项目信息?
请登录 www.lingmed.net/reports
或点击下方“阅读原文”马上下载
